ライフサイエンスコーパス: microdialysis

1 erine concentration in slices and in vivo by microdialysis.

2 s in mesolimbic MOR function suggested by DA microdialysis.

3 e coupling of capillary electrophoresis with microdialysis.

4 els in the NAc shell, as measured by in vivo microdialysis.

5 riatal glutamate were measured using in vivo microdialysis.

6 DAT in vivo using quantitative "no-net-flux" microdialysis.

7 FD in 3 h/day and were monitored with VMH FA microdialysis.

8 f neuronal networks in vivo, we used in vivo microdialysis.

9 yruvate in the vastus lateralis muscle using microdialysis.

10 EC and IC rats was determined using in vivo microdialysis.

11 ng of bisulfide variation in the effluent of microdialysis.

12 dialysate DA concentration as measured with microdialysis.

13 leus accumbens shell (NAcSh) through in vivo microdialysis.

14 ne and PGD2 contractions were measured using microdialysis.

15 t received apoE infusions during brain Abeta microdialysis.

16 nd the caudate nucleus (n = 5) using in vivo microdialysis.

17 DA release at 4 weeks as measured by in vivo microdialysis.

18 e nucleus accumbens decreased as measured by microdialysis.

19 amine output and metabolism was studied with microdialysis.

20 nd the RSC, which was confirmed with in vivo microdialysis.

21 rved in vitro, primary cultures, and in vivo microdialysis.

22 umbens of conscious rats were assessed using microdialysis.

23 rstitial fluid (ISF), as measured by in vivo microdialysis.

24 assessed pharmacologically using intradermal microdialysis.

25 rtex and dorsal striatum measured by reverse microdialysis.

26 s in prefrontal cortex measured with in vivo microdialysis.

27 ed brain Abeta half-life measured by in vivo microdialysis.

28 cose levels were measured continuously using microdialysis.

29 ng indirect calorimetry, blood sampling, and microdialysis.

30 to metabolic crisis as measured by cerebral microdialysis.

31 ippocampus of young APP/PS1 mice via reverse microdialysis.

32 Affinity-enhanced microdialysis (AE-MD) has previously been used to improv

33 which was investigated herein using in vivo microdialysis, after establishing a dose that did not pr

34 Cortical microdialysis and amperometric methods revealed that, wh

35 lamping with concomitant adipose tissue (AT) microdialysis and an in-depth analysis of subcutaneous A

36 n interstitial VMH glutamate levels by using microdialysis and biosensors, 2) identified the receptor

37 .0 mg kg(-1): 2355+/-1026%) as measured with microdialysis and decrease in [(11)C]FLB 457 binding pot

38 We interpret this result to mean that both microdialysis and diffusion tensor magnetic resonance im

39 Using microdialysis and fast-scan cyclic voltammetry in rats,

40 Microdialysis and immunohistochemical studies were perfo

41 hypothesis that intraluminal application of microdialysis and metabolic parameters from the small in

42 Using in vivo microdialysis and microinjection of drugs into the mesol

43 Using in vivo microdialysis and microinjection of drugs into the mesol

44 emission tomography (PET), autoradiography, microdialysis and molecular biology in a putative domina

45 racellular striatal acetylcholine by in vivo microdialysis and paradoxical excitation of cholinergic

46 Microdialysis and PET experiments were performed to comp

47 e IL-6, IL-8 and TNF-alpha collected by skin microdialysis and safety and tolerability of bilastine.

48 The physical lag time between microdialysis and the analytical signal was approximatel

49 ss multiple time scales, using complementary microdialysis and voltammetric methods during adaptive d

50 triatal extracellular dopamine levels (using microdialysis) and dopamine D2/D3 receptor binding (usin

51 ure, brain oxygen tension (PbtO2), and brain microdialysis, and electrodes for electroencephalography

52 , behavioral analyses, pharmacology, in vivo microdialysis, and neuronal activity mapping to assess t

53 Here, we used electrophysiology, microdialysis, and NMR spectroscopy to evaluate the effe

54 Combining neuronal ensemble recordings, microdialysis, and optogenetics, here we show that the b

55 A novel optogenetic-microdialysis approach allowed the measurement of extrac

56 A novel optogenetic-microdialysis approach allowed us to demonstrate that lo

57 A recently introduced in vivo optogenetic-microdialysis approach was used, which allows the measur

58 Here, we utilized optogenetic and reverse-microdialysis approaches to modulate activity of the maj

59 thods to codetect purines, such as HPLC with microdialysis, are robust but lack the temporal resoluti

60 ranial pressure + brain tissue PO2+ cerebral microdialysis (area under the receiver-operating charact

61 icrodialysis probe is critical to the use of microdialysis as a neurochemical analysis technique.

62 We evaluated microdialysis as a tool for early ischemia detection in

63 two techniques - glucose clamps and in vivo microdialysis - as a means to dynamically modulate blood

64 The in vivo brain microdialysis assays demonstrated that R-MOD alone produ

65 ested for selective recognition by combining microdialysis assays with simple isotope labeling and NM

66 thin the amygdala were measured with in vivo microdialysis, at baseline and in response to challenge

67 l types of neurochemical probes ranging from microdialysis-based to enzyme-based carbon fiber microse

68 ed by the lactate/pyruvate ratio using brain microdialysis; both these systems were placed in the rig

69 e have developed an online, high-throughput, microdialysis-capillary electrophoresis (MD-CE) assay fo

70 We have developed a high-throughput microdialysis-capillary electrophoresis (MD-CE) assay fo

71 Anisotropy reductions near microdialysis catheter insertion sites were highly corre

72 m radius white matter-masked region near the microdialysis catheter insertion sites.

73 A microdialysis catheter was placed in the lateral renal c

74 A pressure probe and a microdialysis catheter were placed intradurally at the i

75 The pressure probe and microdialysis catheter were placed on the surface of the

76 uously spinal cord perfusion pressure, and a microdialysis catheter, to monitor hourly glycerol, glut

77 One hundred kilodalton cut-off microdialysis catheters were implanted at a median time

78 Microdialysis catheters were inserted into the abdominal

79 The ability of the in vitro microdialysis-CE instrument to monitor dynamic changes i

80 Ex vivo intradermal microdialysis combined with culture media analysis provi

81 ore than 16 h at 1 min time resolution using microdialysis coupled online to a capillary HPLC system

82 ing behavioral tasks was determined by brain microdialysis coupled to chromatographic-electrochemical

83 In vivo microdialysis demonstrated decreased release of DA after

84 Cerebral microdialysis demonstrated more frequent critical reduct

85 We hypothesized that IL as opposed to IP microdialysis detects small intestinal ischemia with hig

86 Using microdialysis, direct accumbal administration of 1 muM 6

87 ced DA overflow in the NAc was examined with microdialysis early and late during self-administration

88 monitoring of the variation of bisulfide in microdialysis effluents by using a nanoparticle-glutathi

89 Likewise, the administration of E2 by microdialysis, either in the hypothalamic paraventricula

90 tes, which are prone to adsorption losses on microdialysis equipment.

91 oppler flowmetry during low dose intradermal microdialysis ET-1 perfusions (1, 3, 4, 5 and 7 pmol) wi

92 Furthermore, rodent microdialysis experiments also demonstrated that oral ad

93 In vivo microdialysis experiments in rat brain demonstrated that

94 Microdialysis experiments indicated that STN-DBS decreas

95 In line with these observations, microdialysis experiments revealed that local blockade o

96 Further, in vivo microdialysis experiments show that blunted dopaminergic

97 Furthermore, microdialysis experiments showed that soticlestat can su

98 Furthermore, in vivo microdialysis experiments showed that the disruptive pep

99 elease in the mechanisms of STN DBS, further microdialysis experiments showed that when the 5-HT lowe

100 ore, we investigated by neuronal tracing and microdialysis experiments the possible targeting of the

101 al pharmacologic and real-time in vivo brain microdialysis experiments were performed on male prairie

102 tissue and in vivo in rat brain as shown by microdialysis experiments.

103 When assessed by in vivo microdialysis, extracellular kynurenic acid levels were

104 In Protocol 2, an intradermal microdialysis fibre was placed in the skin of the latera

105 ch diet, subjects were instrumented with two microdialysis fibres for the local delivery of Ringer so

106 ects were instrumented with four intradermal microdialysis fibres on the forearm and each randomly as

107 nisms mediating H2 S-induced vasodilatation, microdialysis fibres were perfused with Ringer solution

108 d cyclo-oxygenase (COX) signalling pathways, microdialysis fibres were perfused with Ringer solution

109 For functional studies, microdialysis fibres were placed in the forearm skin of

110 Four microdialysis fibres were placed in the forearm skin of

111 ter and 1 week after the 7 days of RIPC, two microdialysis fibres were placed in ventral forearm skin

112 an analysis, amino acids were sampled using microdialysis, fluorescently labeled in an online reacti

113 Rapid-sampling microdialysis for cortical [lactate] as a marker of tiss

114 Rapid-sampling microdialysis for cortical [lactate] as a marker of tiss

115 In vivo microdialysis for sampling of cancer cell-derived (human

116 ff-line detection from droplets collected by microdialysis for the eventual measurement of neuropepti

117 ed near infrared (NIR) sensor, combined with microdialysis, for continuous glucose monitoring.

118 Microdialysis further reveals that these modes and actio

119 PO2 less than 20 mm Hg (9% vs 20%), cerebral microdialysis glucose less than 1 mmol/L (22% vs 57%), a

120 In experiment 2, using microdialysis, GnRH and kisspeptin surges induced by E2

121 Studies using microdialysis have revealed some qualitative information

122 aracterize glutamate levels in vivo, such as microdialysis, have low spatiotemporal resolution, which

123 ination of behavioral, electrophysiological, microdialysis, immunohistochemical, and Western blot ass

124 ) was performed in conjunction with cerebral microdialysis in a cohort of severe TBI patients with ti

125 Microdialysis in behaving mice confirmed that EE normali

126 release of OXT within the PVN as assessed by microdialysis in combination with a highly sensitive rad

127 We used bilateral microdialysis in freely behaving rats (n = 32), instrume

128 The NE release in the PFC was measured by microdialysis in freely moving mice (n = 55).

129 Microdialysis in freely moving rats revealed that SI was

130 ulation of hippocampal e[GABA] using in vivo microdialysis in freely moving rats.

131 study was to determine the role of cerebral microdialysis in monitoring the efficacy of fractionated

132 ng dual-probe in vivo dopamine and glutamate microdialysis in nucleus accumbens and medial prefrontal

133 ersus with control antibody was monitored by microdialysis in patient-derived GD2-expressing neurobla

134 AMPH concentrations were measured via microdialysis in rat nucleus accumbens after intraperito

135 In vivo microdialysis in rat nucleus accumbens showed that i.v.

136 sing in vitro transporter assays and in vivo microdialysis in rat nucleus accumbens.

137 Using in vivo microdialysis in rats and mice, we demonstrate that intr

138 Thus, we employed microdialysis in rats trained to self-administer intrave

139 Similar findings were obtained by microdialysis in rodents subjected to 1 night of paradox

140 ithin the nucleus accumbens (NAc) by in vivo microdialysis in task-performing animals.

141 Here, we performed in vivo microdialysis in the PFC and NAc in rats following eithe

142 in lipid levels were indexed both by in vivo microdialysis in the VTA and lipid extractions from brai

143 oenvironment by the cancer cells sampled via microdialysis in vivo revealed that 38 proteins were alt

144 Measured in samples obtained by striatal microdialysis in vivo, basal levels of tryptophan, kynur

145 y measured DA efflux in the PFC and NAc with microdialysis in well trained rats performing a probabil

146 uglycemic clamps with concurrent hippocampal microdialysis in young, awake, behaving APPswe/PS1dE9 tr

147 The infusion of an E2 antagonist via reverse microdialysis into the PVN or VMH attenuated the effect

148 ation about what enzymes may be present, but microdialysis is a sampling technique so it is not desig

149 Subcutaneous microdialysis is coupled with ultraperformance liquid ch

150 In-line microdialysis is in this work hyphenated to electrotherm

151 ial pressure, brain tissue PO2, and cerebral microdialysis--is more accurate than intracranial pressu

152 olic crisis as measured by elevated cerebral microdialysis lactate/pyruvate ratio occurred during sei

153 Microdialysis levels of histamine, IL-6 and IL-8 assesse

154 There is growing interest in cerebral microdialysis (MD) for sampling of protein biomarkers in

155 Microdialysis (MD) is a useful sampling tool for many ap

156 This system involved microdialysis (MD) sampling and fluorescence determinati

157 se concentration in living rat brain through microdialysis (MD) sampling in conjunction with (i) onli

158 sing the same experimental set-up as in vivo microdialysis (MD) thus providing a new and exciting too

159 nd a significant inverse correlation between microdialysis measured levels of tau 13-36 h after injur

160 We found that acute microdialysis measurements of the axonal cytoskeletal pr

161 Immunohistochemistry and brain microdialysis measurements were performed.

162 elf-stimulation (ICSS)) or with cannulae for microdialysis measures of nucleus accumbens dopamine (NA

163 cotine flux ratio 6.4 +/- 2.5 as detected in microdialysis membrane probe in skin.

164 In vivo, a microdialysis membrane probe was implanted in skin of HG

165 ng of lead transfer across the permselective microdialysis membrane to mimic the diffusive transport

166 al bovine serum onto the poly(ether sulfone) microdialysis membrane.

167 evice camera as the detector, the integrated microdialysis/microfluidic chip device achieved a detect

168 ial pressure, brain tissue PO2, and cerebral microdialysis monitoring (right frontal lobe, apparently

169 Microdialysis monitoring did not cause serious complicat

170 Here, we describe a bedside microdialysis monitoring technique for optimizing spinal

171 for spinal cord injury include pressure and microdialysis monitoring to optimize spinal cord perfusi

172 l outcome of NMU on NMUR2 was examined using microdialysis (n = 16).

173 the hippocampus in vivo using zero-net-flux microdialysis, negligible GABA is detected by dentate gr

174 However, neither microdialysis nor diffusion tensor magnetic resonance im

175 Reverse microdialysis of cholinergic antagonists within BF preve

176 lation was abolished by simultaneous reverse microdialysis of cholinergic receptor antagonists into B

177 cocaine self-administration in rats.In vivo microdialysis of CRF in the VTA demonstrated that CRF is

178 Microdialysis of GABAA receptor antagonists into the PnO

179 Importantly, in vivo microdialysis of human ER(+) breast cancer revealed that

180 Doppler flowmetry, combined with intradermal microdialysis of l-N(G)-monomethyl-l-arginine, a nitric

181 ivating one IC in guinea pig with cooling or microdialysis of procaine, and recording neural activity

182 the contralateral IC by cryoloop cooling or microdialysis of procaine.

183 of cocaine and heroin determined by in vivo microdialysis, on the reinforcing effects of cocaine and

184 DA signaling was characterized with in vivo microdialysis or fast-scan cyclic voltammetry.

185 No safety concerns arose during either microdialysis or scanning.

186 and brain glucose concentrations measured by microdialysis (p < .0001).

187 etry) was measured during graded intradermal microdialysis perfusion of the endothelium-dependent ago

188 Following microdialysis placement, subjects performed supine cycli

189 The electroosmotic perfusion-microdialysis probe and associated method were used to d

190 chip with enzymatic microreactor (EMR) to a microdialysis probe and evaluated the performance of thi

191 ostatic interaction between peptides and the microdialysis probe because modification increased recov

192 Distinct microdialysis probe configurations and membranes types w

193 The microdialysis probe construction and insertion procedure

194 acellular recordings performed proximal to a microdialysis probe during local infusion of vehicle, th

195 Capitalized upon a concentric microdialysis probe immersed in synthetic gut fluids, th

196 e of the interface between the brain and the microdialysis probe is critical to the use of microdialy

197 It also has a microdialysis probe to collect products and unreacted su

198 easurements, the brain tissue containing the microdialysis probe tracks was examined by fluorescence

199 placed in-line between the syringe pump and microdialysis probe.

200 direct contact with the porous membrane of a microdialysis probe.

201 ing or after biofilm formation directly on a microdialysis probe.

202 the polymeric semipermeable membrane of the microdialysis probe.

203 eletion by histology, electrophysiology, and microdialysis; probed neuronal activation by c-Fos immun

204 Microdialysis probes (n = 125) coupled to depth electrod

205 electrically evoked dopamine release next to microdialysis probes during the retrodialysis of dexamet

206 m that integrates with FDA-approved clinical microdialysis probes for continuous monitoring of human

207 We use two microdialysis probes implanted at opposite ends of a mic

208 the penetration injury caused by implanting microdialysis probes into brain tissue.

209 Microdialysis probes were implanted into the hypoglossal

210 Microdialysis probes were implanted into the inguinal ad

211 Two microdialysis probes were inserted into the dermis on th

212 gmine in different spatial locations via the microdialysis probes while we concomitantly recorded neu

213 NR2A-containing receptors, perfused through microdialysis probes, markedly reduced cortex susceptibi

214 nductance were measured over two intradermal microdialysis probes, one perfused with ISO saline and t

215 less than that of the smallest conventional microdialysis probes.

216 mol/L NaOH and sampled using laboratory-made microdialysis probes.

217 nuclei than larger sampling devices, such as microdialysis probes.

218 We conducted immunoblotting and in vivo microdialysis procedures in MA high/low drinking mice, a

219 Using in vivo microdialysis procedures, extracellular glutamate (GLUEX

220 Microdialysis provided an early warning of arterial occl

221 r treatment with d-Amphetamine using in vivo microdialysis, quantified levels of tyrosine hydroxylase

222 centration of glutamine measured by cerebral microdialysis reflected the beneficial effects of FPSA t

223 We hypothesized that in ALF cerebral microdialysis reflects the benefits of FPSA treatment on

224 nd a perfusate flow rate of 2.0 muL min(-1), microdialysis relative recoveries in the gastric phase w

225 Voltammetry measurements supported the microdialysis results by showing that nicotine withdrawa

226 The combination of the swelling and microdialysis results provides a fresh understanding on

227 Intracerebral microdialysis revealed a lower level of acetylcholine in

228 of hippocampal interstitial fluid by in vivo microdialysis revealed a significant elevation in lactat

229 Skin microdialysis revealed elevated VEGF-A protein levels at

230 Microdialysis revealed marked decreases in cocaine-induc

231 Finally, quantitative "no-net-flux" microdialysis revealed reduced extracellular baseline DA

232 The in vivo microdialysis revealed that alphaCaMKII(T286A) mice show

233 In the mPFC, in vivo microdialysis revealed that extracellular 5-HT levels we

234 In vivo microdialysis revealed that N/OFQ prevented dyskinesias

235 Nanoliter volumes of microdialysis sample are efficiently reacted with contin

236 Microdialysis samples were collected from female rats th

237 ted within suspected seizure onset sites and microdialysis samples were obtained during interictal pe

238 a proteins, were measured every 1-2 h in the microdialysis samples.

239 hemical dynamics in model cell systems using microdialysis sampling coupled with high-speed capillary

240 Microdialysis sampling in the brain is employed frequent

241 Microdialysis sampling is an essential tool for in vivo

242 asuring their concentration in vivo by using microdialysis sampling is challenging due to their low c

243 In vivo neurochemical monitoring using microdialysis sampling is important in neuroscience beca

244 In this work, microdialysis sampling procedures were optimized to coll

245 nfirm cell viability and confluency over the microdialysis sampling region.

246 imentally validated by comparison of in situ microdialysis sampling results with in-line microfiltrat

247 s of the analysed compounds as a function of microdialysis sampling time.

248 This work demonstrates the initial use of microdialysis sampling to collect quorum sensing signali

249 In situ automatic microdialysis sampling under batch-flow conditions is he

250 Microdialysis sampling was coupled with online, high-spe

251 In addition, in vivo microdialysis showed that systemic U69,593 decreased ove

252 At the end of cycling, all microdialysis sites were locally heated to 43 degrees C

253 d in three protocols: in Protocol 1 (n = 8), microdialysis sites were perfused with lactated Ringer s

254 Additional in vivo microdialysis studies also show that this compound decre

255 recognition task and water maze and in brain microdialysis studies at lower doses.

256 Microdialysis studies demonstrated that both R- and S-mo

257 In microdialysis studies i.v. PRE-084 did not significantly

258 R- and S-modafinil were also evaluated in microdialysis studies in the mouse nucleus accumbens she

259 cortisone was used as a challenge because in microdialysis studies it has been shown to increase cort

260 Microdialysis studies revealed that both JJ-3-42 and lor

261 Microdialysis studies revealed that either systemic admi

262 Microdialysis studies were performed to evaluate dopamin

263 In microdialysis studies, 5bb increased the dopamine efflux

264 nt euglycemic-hyperinsulinemic clamp, muscle microdialysis studies, and muscle biopsies.

265 staglandin concentration by 62%, as shown in microdialysis studies.

266 By use of in vivo microdialysis techniques in freely moving rats and micro

267 We employed advanced opioid microdialysis techniques that allow detection of extrace

268 s of fluorescent false neurotransmitters and microdialysis techniques to unveil that cocaine and meth

269 e cycle has mainly been studied in vivo with microdialysis techniques.

270 tape stripping/dermatopharmacokinetics, and microdialysis) techniques.

271 Microdialysis, the standard technique to study brain met

272 is fully enclosed and can be integrated with microdialysis to allow continuous monitoring of tissue m

273 been successfully combined with subcutaneous microdialysis to continuously monitor glucose in rats.

274 We used microdialysis to deliver artificial extracellular fluid

275 eriment 3), while concurrently using in vivo microdialysis to measure hippocampal ACh efflux.

276 We use microdialysis to passively extract soil solution spiked

277 al models of self-administration and in vivo microdialysis to study the pharmacological actions of R-

278 re we used a (3)H-glutamate uptake assay and microdialysis to test the hypothesis that ceftriaxone re

279 The current study used reverse microdialysis to test the hypothesis that the preferenti

280 sphorylation) and glutamate release (in vivo microdialysis) upon ILC electrical stimulation.

281 elay, p = 0.150), intracranial pressure, and microdialysis values.

282 In vivo microdialysis was carried out in rat nucleus accumbens t

283 Brain microdialysis was done simultaneously.

284 Microdialysis was performed using a flow rate of 3 muL/m

285 In vivo microdialysis was used to investigate IFN-alpha effects

286 In vivo microdialysis was used to measure acute heroin-induced i

287 Intradermal microdialysis was utilized for up to 24h after drug appl

288 re, using a unique large pore-sized membrane microdialysis, we characterized soluble Abeta oligomers

289 Using in vivo microdialysis, we demonstrated stimulation of the NO-sGC

290 ptical stimulation with simultaneous in vivo microdialysis, we demonstrated that optical stimulation

291 Using neurotoxic lesions and microdialysis, we examined whether the mPOA modulates co

292 Using in vivo microdialysis, we found that VU0152100 reversed amphetam

293 is" probe to couple optogenetics and in vivo microdialysis, we report that optical stimulation of bas

294 Using chemogenetics and microdialysis, we show that, in sign-trackers, stimulati

295 Using microdialysis, we showed that the release of NE evoked i

296 nditioned place preference (CPP) and in vivo microdialysis were used to assess negative reinforcement

297 nally, estradiol microinjections followed by microdialysis were used to determine whether estrogenic

298 nset of ischemia earlier than intraperioneal microdialysis with higher sensitivity and specificity.

299 raphysiologic hyperinsulinemia, by combining microdialysis with oral glucose tolerance tests and eugl

300 sites continuously perfused via intradermal microdialysis with: (1) lactated Ringer solution (Contro